<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04801459</url>
  </required_header>
  <id_info>
    <org_study_id>DJY002</org_study_id>
    <nct_id>NCT04801459</nct_id>
  </id_info>
  <brief_title>Study on the Peristaltic Direction of Gastrointestinal Anastomosis in Roux-en-Y Reconstruction After Distal Curative Gastrectomy</brief_title>
  <official_title>A Single Center Randomized Prospective Study on the Peristaltic Direction of Gastrointestinal Anastomosis in Roux-en-Y Reconstruction After Distal Curative Gastrectomy for Gastric Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tianjin Medical University Cancer Institute and Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tianjin Medical University Cancer Institute and Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is intending to provide the optimal procedures of the peristaltic&#xD;
      direction of gastrointestinal anastomosis in Roux-en-Y reconstruction after distal curative&#xD;
      gastrectomy for gastric cancer, which can provide the best operation mode of Roux-en-Y&#xD;
      anastomosis in digestive tract reconstruction during distal gastrectomy for reducing&#xD;
      postoperative complications and improving quality of life for patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Early postoperative recovery results</measure>
    <time_frame>Within 1 month after surgery</time_frame>
    <description>Differences of effects of early recovery postoperatively (exhaust, defecation, eating, residual stomach peristalsis, length of hospital stay, etc.)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Late postoperative recovery results</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Differences of late gastrointestinal effects (bile reflux, residual gastritis, gastric emptying function, etc.)</description>
  </primary_outcome>
  <other_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>Within 1 month after surgery</time_frame>
    <description>Postoperative incision infection, anastomotic leakage, intestinal obstruction, reoperation and readmission, etc</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">148</enrollment>
  <condition>Peristaltic Direction</condition>
  <condition>Roux-en-Y Gastrointestinal Anastomosis</condition>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>Antiperistaltic direction of gastrointestinal anastomosis in Roux-en-Y reconstruction group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Isoperistaltic direction of gastrointestinal anastomosis in Roux-en-Y reconstruction group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Direction procedure of gastrointestinal anastomosis in Roux-en-Y reconstruction</intervention_name>
    <description>In this study, intervention methods include two kind directions of gastrointestinal anastomosis in Roux-en-Y reconstruction after distal curative gastrectomy for gastric cancer. One is the isoperistaltic anastomosis, representing the peristalsis direction of remnant stomach and jejunal efferent loop was consistent. The other is the antiperistaltic anastomosis, representing the peristalsis direction of remnant stomach and jejunal efferent loop was opposite.</description>
    <arm_group_label>Antiperistaltic direction of gastrointestinal anastomosis in Roux-en-Y reconstruction group</arm_group_label>
    <arm_group_label>Isoperistaltic direction of gastrointestinal anastomosis in Roux-en-Y reconstruction group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1) Pathological examination confirmation the adenocarcinoma of stomach before surgery&#xD;
&#xD;
          -  2) Physical conditions compliance with the requirements for curative gastrectomy&#xD;
&#xD;
          -  3) Consent to undergo the D2 lymphadenectomy, and the dissected proportion of stomach&#xD;
             no less than 2/3&#xD;
&#xD;
          -  4) Comply with the protocol during the whole study period&#xD;
&#xD;
          -  5) No neoadjuvant therapy administration&#xD;
&#xD;
          -  6) Sign informed consent and permission of withdraw in the whole study period&#xD;
&#xD;
          -  7) Consent to provide the tissue specimens after surgery for this study&#xD;
&#xD;
          -  8) Estimation the overall survival after surgery no less than 6 months&#xD;
&#xD;
          -  9) No anesthesia or operation contraindication disease&#xD;
&#xD;
          -  10) cT1-4N0-2M0 stage demonstration by CT and endoscopic ultrasonography examinations&#xD;
&#xD;
          -  11) Negative cytological detection in operation&#xD;
&#xD;
          -  12) No seriously concomitance's diseases&#xD;
&#xD;
          -  13) Karnofsky Performance Scores (KPS) more than 60&#xD;
&#xD;
          -  14) Examined lymph node count no less than 16&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1) Women during pregnant stage and breast-feed stage&#xD;
&#xD;
          -  2) Women of childbearing age without any contraceptive measures&#xD;
&#xD;
          -  3) Severe congestive heart failure, frequent arrhythmia, or myocardial infarction&#xD;
             within 12 months&#xD;
&#xD;
          -  4) Immunosuppressive therapists for organ transplantation&#xD;
&#xD;
          -  5) Seriously uncontrolled recurrent infection&#xD;
&#xD;
          -  6) other malignant tumors&#xD;
&#xD;
          -  7) No abilities of self-knowledge or mental disorders&#xD;
&#xD;
          -  8) Participating in other clinical trials&#xD;
&#xD;
          -  9) Siewert I and II esophagogastric junction tumors&#xD;
&#xD;
          -  10) Serious internal diseases obstruction surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jingyu Deng, M.D.</last_name>
    <phone>+86-22-23340123</phone>
    <email>dengery@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Han Liang, M.D.</last_name>
    <phone>+86-22-23340123</phone>
    <email>tjlianghan@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cancer Hospital of Tianjin Medical University</name>
      <address>
        <city>Tianjin</city>
        <zip>300060</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jingyu Deng, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 10, 2021</study_first_submitted>
  <study_first_submitted_qc>March 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2021</study_first_posted>
  <last_update_submitted>April 6, 2021</last_update_submitted>
  <last_update_submitted_qc>April 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 30, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/59/NCT04801459/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 30, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/59/NCT04801459/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 30, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/59/NCT04801459/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

